<DOC>
<DOCNO>
EP-0017379
</DOCNO>
<TEXT>
<DATE>
19801015
</DATE>
<IPC-CLASSIFICATIONS>
A61P-25/02 A61P-27/12 C07D-491/00 C07D-495/10 A61P-3/00 A61P-3/10 A61K-31/415 C07D-311/22 A61P-13/02 C07D-495/00 C07D-235/02 A61P-27/00 A61K-31/4184 C07D-311/00 <main>C07D-235/02</main> A61P-13/00 A61K-31/4164 A61P-27/02 C07D-235/00 A61P-3/08 A61P-15/00 C07D-491/107 A61P-25/00 C07D-491/10 
</IPC-CLASSIFICATIONS>
<TITLE>
phenyl or phenoxy substituted spiro-imidazolidinedione derivatives, pharmaceutical compositions thereof and process for their preparation.
</TITLE>
<APPLICANT>
pfizerus<sep>pfizer inc.<sep>pfizer inc.235 east 42nd streetnew york, n.y. 10017us<sep>pfizer inc.<sep>
</APPLICANT>
<INVENTOR>
belletire john<sep>sarges reinhard<sep>belletire, john<sep>sarges, reinhard<sep>belletire, john10b university housesmadison, county of dane wisconsinus<sep>sarges, reinhardriver roadmystic, new london connecticutus<sep>belletire, john<sep>sarges, reinhard<sep>belletire, john10b university housesmadison, county of dane wisconsinus<sep>sarges, reinhardriver roadmystic, new london connecticutus<sep>
</INVENTOR>
<ABSTRACT>
novel phenyl or phenoxy substituted spiro-imidazol­ idinedione derivatives of the formula    wherein x is o, s, so or so₂ y is h, ch₃, ch₃o, ph, pho, f, cl  or br at the 6 or 8 position and ar is ph or oph at the 6 or 8  position, are useful as aldose reductase inhibitors and as  therapeutic agents for the treatment of chronic diabetic  complications.  the derivatives include the phenyl or phe­ noxy substituted spiro-imidazolidene naphthalene, chroman,  thiochroman sulfoxychroman, sulfonochroman dione com­ pounds and the substituted forms thereof.  a process for their  preparation and pharmaceutical composition are also  claimed.  
</ABSTRACT>
</TEXT>
</DOC>
